Stay updated on Pembrolizumab SubQ vs IV in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab SubQ vs IV in Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab SubQ vs IV in Melanoma Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe record history now lists Revision: v3.6.5 and no longer shows Revision: v3.6.4, reflecting a new build of the site’s history UI. This change documents the latest platform update without altering study information.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedThe page now shows Revision: v3.6.4 in the footer, replacing Revision: v3.6.3, indicating a platform/UI update.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3, indicating a small behind-the-scenes platform version update. This change does not alter study data or visible features.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision: v3.6.2 appears in the page history, replacing the previous Revision: v3.6.0. This reflects a minor update to the revision metadata of the record and does not change study data or public content.SummaryDifference0.1%

- Check73 days agoChange DetectedA new revision v3.6.0 adds a note that the study is no longer looking for participants, and the previous revision v3.5.5 is removed from the history.SummaryDifference0.3%

- Check80 days agoChange DetectedNew revision v3.5.5 is added to the study history, replacing the previous revision v3.5.4. This indicates an update to the record's version rather than substantive content changes.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab SubQ vs IV in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab SubQ vs IV in Melanoma Clinical Trial page.